Home/Filings/4/0001209191-22-020585
4//SEC Filing

Chardonnet Laurent 4

Accession 0001209191-22-020585

CIK 0001678660other

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 6:01 PM ET

Size

4.6 KB

Accession

0001209191-22-020585

Insider Transaction Report

Form 4
Period: 2022-03-21
Chardonnet Laurent
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-03-21$7.51/sh+6,500$48,81514,500 total

Issuer

Prelude Therapeutics Inc

CIK 0001678660

Entity typeother

Related Parties

1
  • filerCIK 0001329010

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 6:01 PM ET
Size
4.6 KB